Home / Conferences

Conferences

World Biosimilar Congress Europe 2015

World Biosimilar Congress Europe 2015
9─11 November| Congress Center| Basel, Switzerland

BioProduction 2015

BioProduction 2015
14‒15 October 2015
Citywest Hotel, Conference & Event Centre
Dublin, Ireland

2nd Annual Oncology Asia

Join us this 7‒9 September 2015 in Tokyo, Japan for the 2nd Annual Oncology Asia conference to learn about the latest trends in new drug discovery and commercialization strategies for oncology biologicals in Asia. Learn from successful case studies from Global and Regional leaders in the Oncology space!

French generics association promotes biosimilars

French generics association GEMME held its first symposium on the challenges and opportunities associated with biosimilars in France on 3 October 2014.

Topics presented at the 16th IGPA conference on generics

Topics presented at the 16th Annual IGPA Conference, held in Brussels, Belgium, 9–11 December 2013, showed that despite differences in the pharmaceutical market in different countries most appreciate the value of generics. In most cases this is driven by cost reduction.

EGA pushes for increased focus on generics and biosimilars

EGA President Ms Gudbjorg Edda Eggertsdottir, speaking at the European Generic medicines Association’s (EGA’s) conferences in London, UK (11th EGA International Symposium on Biosimilar Medicines) and in Athens, Greece (19th EGA Annual Conference); stressed the importance of keeping generics and biosimilars manufacturers within Europe, thus ensuring that high quality manufacturing jobs and know-how remains in Europe. This would benefit society and patients and increase the competitiveness and innovative capacity of the pharmaceutical industry in Europe.

Report on 25th Annual EuroMeeting, 4-6 March 2013, Amsterdam, The Netherlands

Delegates at DIA’s 25th Anniversary of the EuroMeeting, held on 4–6 March 2013 in Amsterdam, The Netherlands, were offered the mouth watering prospect of more than 100 sessions across 17 themes, addressed by 300+ Speakers from EMA, European Commission, FDA and other national regulatory agencies. Most popular sessions included Implementation of the New Pharmacovigilance Legislation, the Regulatory Town Hall Meeting and the sell-out European Landscape on HTA - the EUnetHTA Joint Action. Eighteen pre-conference tutorials were led by an expert faculty and 120 students, young professional and patients all attended sessions created especially for them.

Patient power predominates at DIA Europe’s Clinical Forum

DIA Europe’s 2012 Clinical Forum in October this year promises to be an important multidisciplinary conference for all engaged in the clinical development and therapeutic use of medicines. The theme for 2012 is ‘The Empowered Patient’, an acknowledgement of the inescapable fact that the evolution of technology and electronic communication has given patients the ability to find and share health information which will impact their treatment choices – empowering them to become more engaged in their care and to participate in decisions about it.

Need for global development programme for biosimilars

There is now a crucial need for a framework that allows global biosimilars development.

European Commission calls for wider use of generic medicines

At the 10th International Symposium on Biosimilar Medicines, organised by the European Generics medicines Association, held in London, UK, on 19–20 April 2012; the European Commission (EC) highlighted the need to stimulate wider use of generic medicines.

Generics News Research General

more

Biosimilars News Research General

more